Publication,

Doing Business in Germany 2019 (Bilingual)

Current site :    CN   |   EN
Australia
Belgium
China
China Hong Kong SAR
Germany
Italy
Japan
Singapore
Spain
UAE
United Kingdom
United States
Global

Many German companies have established enterprises, joint ventures or subsidiaries in China. In recent years, a large number of Chinese companies have invested in Germany – and even more are expected to do so in the years to come.

In undertaking investments, Chinese enterprises often ask questions that go beyond law, such as, to put it simply: "How do we do it?" and "What are the key issues we will face?".

These questions, amongst many others, are answered in this publication, providing an initial overview of some of the key issues that are likely to be of interest to Chinese entities seeking investment opportunities in Germany.


* KWM global network has produced a series publications in doing business overseas, which can also be accessed via website or intranet. These include:

"Doing Business in China" (EN) 

"Doing Business in the U.S." (CN) 

"Doing Business in the UK" (CN & EN) 

"Doing Business in Spain" (CN) 

"Doing Business in the Middle East" (CN & EN) 

"Doing Business in Japan" (CN & EN) 




DOWNLOAD PUBLICATION
Doing Business in Germany
This publication introduces the general situations of foreign enterprises investing in Germany and the specific legal issues concerned.

Download

1.25MB, 24 Pages

LATEST THINKING
Insight
New regulations in China designed to encourage innovation in clinical trials have made it easier to test human samples in a lab setting.

19 May 2022

Publication
Since 2017, KWM has issued the Series, Think Tank Report: Law and Practice under the Belt and Road Initiative. As the fifth instalment of the Series, this pamphlet comprises two parts: “Overview” and “Introduction by Countries”. Authored by KWM lawyers focusing on investment, financing, construction and projects, M&A, trade, compliance, and dispute resolution, this pamphlet will present you our experience and insights from different perspectives.

14 May 2022

Insight
Under the Chinese medical device regulatory regime, as filing/registration is compulsory prior to marketization, the legality of use of unregistered in vitro diagnostics reagents (“IVD”) in laboratory-developed testing (“LDT”) has been in a grey area for a long time.

10 May 2022